Literature DB >> 22093712

2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Bernard J Gersh, Barry J Maron, Robert O Bonow, Joseph A Dearani, Michael A Fifer, Mark S Link, Srihari S Naidu, Rick A Nishimura, Steve R Ommen, Harry Rakowski, Christine E Seidman, Jeffrey A Towbin, James E Udelson, Clyde W Yancy.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 22093712     DOI： 10.1016/j.jtcvs.2011.10.019

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN： 0022-5223            Impact factor:   5.209


× No keyword cloud information.
  18 in total

Review 1.  Sleep-disordered breathing in hypertrophic cardiomyopathy: challenges and opportunities.

Authors:  Tomas Konecny; Virend K Somers
Journal:  Chest       Date:  2014-07       Impact factor: 9.410

Review 2.  Novel Therapies for Prevention and Early Treatment of Cardiomyopathies.

Authors:  Giuliana G Repetti; Christopher N Toepfer; Jonathan G Seidman; Christine E Seidman
Journal:  Circ Res       Date:  2019-05-24       Impact factor: 17.367

3.  Hypertrophic cardiomyopathy in children.

Authors:  Arman Arghami; Joseph A Dearani; Sameh M Said; Patrick W O'Leary; Hartzell V Schaff
Journal:  Ann Cardiothorac Surg       Date:  2017-07

Review 4.  Implantable cardioverter defibrillator therapy in hypertrophic cardiomyopathy: an updated systematic review and meta-analysis of outcomes and complications.

Authors:  Nelson Wang; Ashleigh Xie; Richard Tjahjono; David H Tian; Steven Phan; Tristan D Yan; Pietro Bajona; Kevin Phan
Journal:  Ann Cardiothorac Surg       Date:  2017-07

5.  Hypertrophic obstructive cardiomyopathy: the Mayo Clinic experience.

Authors:  Kunal D Kotkar; Sameh M Said; Joseph A Dearani; Hartzell V Schaff
Journal:  Ann Cardiothorac Surg       Date:  2017-07

6.  199th ENMC international workshop: FHL1 related myopathies, June 7-9, 2013, Naarden, The Netherlands.

Authors:  Anne T Bertrand; Carsten G Bönnemann; Gisèle Bonne
Journal:  Neuromuscul Disord       Date:  2014-02-14       Impact factor: 4.296

Review 7.  Precision Cardiovascular Medicine: State of Genetic Testing.

Authors:  John R Giudicessi; Iftikhar J Kullo; Michael J Ackerman
Journal:  Mayo Clin Proc       Date:  2017-04       Impact factor: 7.616

Review 8.  Evaluation of Hypertrophic Cardiomyopathy: Newer Echo and MRI Approaches.

Authors:  Manhal Habib; Sara Hoss; Harry Rakowski
Journal:  Curr Cardiol Rep       Date:  2019-06-26       Impact factor: 2.931

9.  Aborted sudden cardiac death (SCD) in a patient with hypertrophic cardiomyopathy (HCM) with low-risk factors for SCD.

Authors:  Sashank Kaushik; Stalin Ramakrishnan Subramanian; Shahrokh Rafii; Ricardo Castillo
Journal:  BMJ Case Rep       Date:  2013-01-25

10.  Appropriate and inappropriate shocks in hypertrophic cardiomyopathy patients with subcutaneous implantable cardioverter-defibrillators: An international multicenter study.

Authors:  Babak Nazer; Zack Dale; Gianmarco Carrassa; Nosheen Reza; Tuna Ustunkaya; Nikolaos Papoutsidakis; Andrew Gray; Stacey J Howell; Miriam R Elman; Paolo Pieragnoli; Giuseppe Ricciardi; Daniel Jacoby; David S Frankel; Anjali Owens; Iacopo Olivotto; Stephen B Heitner
Journal:  Heart Rhythm       Date:  2020-02-18       Impact factor: 6.343
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.